Research makes strong case for broader use of GLP1 drugs to protect hearts
New research being presented at the annual meeting of the European Association for the Study of Diabetes (EASD)…
Weight-loss drugs v AI: Which one will reshape the economy first – Liam Dann
I don’t doubt it will, but there is uncertainty about the timing. Meanwhile, there’s been plenty of talk…
GLP-1 agonist semaglutide slows aging in mice
Researchers say that starting an aging mouse on semaglutide can extend its lifespan and delay certain well-known…
What are the benefits and risks of GLP-1 drugs beyond weight loss?
BATON ROUGE, La. (WAFB/Gray News) — Doctors have used GLP-1 drugs for weight loss for about five years,…
11 Best Supplements to Take While on GLP-1s According to Experts 2026
GLP-1 medications have been on the rise for years due to their multifaceted weight-loss benefits. Now, getting your…
11 Things People Keep Getting Wrong About GLP-1s
There’s no question that GLP-1 receptor agonist drugs like Wegovy and Ozempic have shifted how we think about…
13 surprising ways GLP-1 weight-loss drugs may benefit the body, according to science
A condition-by-condition guide to GLP-1 drugs breaks down what’s proven, what’s promising and what’s still untested. Humans have…
Colorado bill targets compounded weight loss drugs
A bipartisan bill at the state capitol in Denver is targeting compounded versions of popular weight loss drugs…
Half of GLP-1 users ditch their injections — and some are turning to other weight-loss methods instead
Published: Jan. 15, 2026 at 11:51 a.m. ET Millions of Americans have tried GLP-1s, but some people find that…
Fitness coach warns that GLP-1 weight loss drugs aren’t for everyone, explains who they are really meant for
Weight loss is rarely a straight path – it can be a long, challenging journey filled with ups…
Wegovy pill could deliver as much weight loss as the shot, trial shows
Eli Lilly and Novo Nordisk are vying for supremacy in the weight-loss market they dominate as they both…
GLP-1s’ Preoperative Use Requires Safety Considerations
Preoperative glucagon-like peptide-1 (GLP-1) receptor agonist therapy did not increase perioperative risks in individuals with obesity or overweight,…